High-protein (HP) diets may attenuate bone loss during energy restriction. The objective of the current study was to determine whether HP diets suppress bone turnover and improve bone quality in male rats during food restriction and whether dietary protein source affects this relation. Eighty 12-wk-old male Sprague Dawley rats were randomly assigned to consume 1 of 4 study diets under ad libitum (AL) control or restricted conditions [40% food restriction (FR)]: 1) 10% [normal-protein (NP)] milk protein; 2) 32% (HP) milk protein; 3) 10% (NP) soy protein; or 4) 32% (HP) soy protein. After 16 wk, markers of bone turnover, volumetric bone mineral density (vBMD), microarchitecture, strength, and expression of duodenal calcium channels were assessed. FR increased bone turnover and resulted in lower femoral trabecular bone volume (P < 0.05), higher cortical bone surface (P < 0.001), and reduced femur length (P < 0.01), bending moment (P < 0.05), and moment of inertia (P = 0.001) compared with AL. HP intake reduced bone turnover and tended to suppress parathyroid hormone (PTH) (P = 0.06) and increase trabecular vBMD (P < 0.05) compared with NP but did not affect bone strength. Compared with milk, soy suppressed PTH (P < 0.05) and increased cortical vBMD (P < 0.05) and calcium content of the femur (P < 0.01) but did not affect strength variables. During AL conditions, transient receptor potential cation channel, subfamily V, member 6 was higher for soy than milk (P < 0.05) and HP compared with NP (P < 0.05). These data demonstrate that both HP and soy diets suppress PTH, and HP attenuates bone turnover and increases vBMD regardless of FR, although these differences do not affect bone strength. The effects of HP and soy may be due in part to enhanced intestinal calcium transporter expression.
Introduction
Energy restriction (ER) 6 and subsequent weight loss results in acute bone loss in humans (1) (2) (3) (4) (5) and laboratory animals (6-8).
On average, for a 10% weight loss, bone mass declines by 1-2% depending on the skeletal site measured (9) . Weight loss also results in declines in fractional calcium absorption and endocrine changes, which may partially explain the bone loss observed during ER (9) . However, consuming protein in excess of the current RDA (0.8 g Á kg 21 Á d
21
) may protect bone health during weight loss (10) . For example, consuming high-protein (HP) diets with adequate calcium intake attenuated bone loss in response to ER in humans when compared with a normalprotein (NP), adequate-calcium diet, despite increased urinary calcium excretion (11) . Interestingly, not all animal studies demonstrate a benefit from HP diets during ER. In 1 study in male rats, 5 mo of an HP (26% casein) diet did not attenuate decrements in calcium retention or femoral bone mineral density (BMD) compared with control (13% casein) (12) . In contrast, another study with aged rats demonstrated that a protein-supplemented diet improved trabecular indices of bone health during ER, whereas no beneficial effect from HP was observed in the cortical compartment (13) .
Dietary protein source (S) may also affect bone health, although whether animal-or plant-based proteins confer the greatest benefit is not clear. Beneficial associations between plant-based protein diets and bone health have been reported (14) , whereas positive effects of animal-based proteins, such as those found in milk, have also been observed (11) . In addition, a high animal-based protein diet may augment intestinal calcium absorption compared with high vegetable-based proteins, such as soy, suggesting that animal protein may confer greater skeletal benefit compared with soy (15) . However, a recent meta-analysis failed to detect an effect of soy or vegetable protein compared with animal protein on BMD, whereas total protein intake was positively associated with both BMD and bone mineral content at several clinically relevant sites (16) .
The objectives of the current study were to replicate the effects of prolonged 40% food restriction (FR) on BMD, bone quality, and bone strength in male rats and to determine whether HP diets attenuate FR-induced decrements in bone quality. Our intent was to develop a model for additional mechanistic exploration and expand on recent findings that characterize the effects of dietary protein on musculoskeletal health during ER in humans (17) (18) (19) (20) . This study also evaluated whether the effect of dietary protein on BMD and bone quality during FR is modulated by S and determined whether these dietary energy and protein manipulations differentially regulate intestinal calcium transporter expression. We hypothesized the following: 1) prolonged FR would decrease BMD, bone quality, and bone strength in rats; 2) HP intake would attenuate the negative effects of FR on bone; 3) milk compared with soy would confer greater skeletal protection during FR; and 4) HP intake would increase intestinal calcium transport protein expression.
Methods
Experimental design. Twelve-week-old male Sprague Dawley rats (n = 80; Charles River Laboratories) were maintained in a temperaturecontrolled environment with a standard 12-h light/dark cycle and unlimited access to reverse-osmosis purified water and AIN-93M purified rodent diet. After a 2-wk acclimation period, rats were randomly assigned to consume 1 of 4 study diets for 16 wk: 1) 10% (NP) milk; 2) 32% (HP) milk; 3) 10% (NP) soy protein; 4) or 32% (HP) soy protein. Diets were consumed at either typical ad libitum (AL) levels or FR (60% of AL) such that there were 8 study groups in total (Supplemental Fig. 1 ). At the conclusion of the intervention, blood, femurs, lumbar spine, and duodenal mucosa were harvested. All study procedures were approved by the U.S. Army Research Institute of Environmental Medicine Animal Care and Use Committee.
Dietary intervention. Purified study diets, based on AIN-93 (21), were formulated and produced by Dyets ( Table 1) . Milk (Idaho Milk Products) and soy (ADM Specialty Food Ingredients) proteins were provided as concentrates and chemically analyzed for nutrient content by an independent laboratory (Covance Laboratories). The milk protein concentrate contained casein and whey proteins in the same ratio as in commercially available cowÕs milk. The total isoflavone content of the milk and NP-soy diets was <10 mg/g, and the total isoflavone content of the HP-soy was 41.9 mg/g. Body weight was determined twice weekly, and feed intake was determined every 2 d (Ohaus).
Blood and tissue collection. After the 16-wk feeding period and overnight food deprivation, rats were killed by carbon dioxide inhalation and exsanguination. Blood was collected by cardiac puncture, and sera were isolated and frozen at 280°C until analysis. One femur and the third lumbar vertebra were collected and frozen at 220°C for subsequent analysis by microcomputed tomography (mCT) and a 3-point bend test, and the second femur was processed for mineral analysis. The first part of the small intestine distal to the pyloric sphincter up to the ligament of Treitz (the duodenum) was removed and immediately placed in ice-cold saline. The intestinal lumen was rinsed, and the mucosa was removed by scraping, immediately frozen in liquid nitrogen, and stored at 280°C until analysis.
Circulating hormones and markers of bone turnover. Serum intact parathyroid hormone (PTH) and osteocalcin were determined by multiplex (Millipore). Serum total calcium was determined by colorimetric assay (Sekisui Diagnostics P.E.I.). Serum insulin-like growth factor-1 (IGF-1) was determined by ELISA (R&D Systems). Serum collagen type 1 cross-linked C-terminal telopeptide (CTX; RatLaps) and procollagen type 1 N-terminal propeptide (P1NP) were determined by ELISA (Immunodiagnostic Systems).
Measures of BMD, microarchitecture, and strength. Bone structure and BMD were determined using mCT as described previously (22, 23) . Briefly, after drying overnight at 95°C, bones were weighed, and their length and midshaft diameter were measured using a Max Cal Digital Caliper (Fred V. Fowler). Bones were scanned using a Scanco mCT scanner (mCT-40; Scanco Medical) at 16-mm isotropic voxel size with x-ray source power of 55 kV and 145 mA and integration time of 300 ms. The scanned grayscale images were processed using a low-pass Gaussian filter (sigma = 0.8, support = 1) to remove background, and a fixed threshold of 220 was used to extract the mineralized bone from soft tissue and marrow phase. For distal femoral trabecular bone analyses, a region of interest that consists of 100 slices starting from ;1 mm distal to the growth plate was chosen. For the third lumbar vertebra analysis, the entire secondary spongiosa between the cranial and caudal areas was scanned and analyzed. For assessment of cortical indices, a scan of 100 slices at the femoral midshaft was analyzed. Bone nomenclature followed recommended standards (24) . After mCT analyses, femurs were subjected to a 3-point bend test using a custom-designed and custom-built apparatus to determine breaking variables of the femur diaphysis as described previously (25) . Briefly, femurs were loaded posterior side down, fulcra length was 6.4 mm, and load was detected using a LeBow Load Cell Model 3168 (capacity of 100 lb; Eaton). Femurs were loaded to failure at a rate of 5 mm/min and a displacement distance (deformation) vs. force curve generated by the software. Yield point force was determined by fitting a least-squares regression line to the linear portion of the deformation vs. force curve; the point at which the bone no longer exhibited elastic deformation was the yield point.
Bending moment was then calculated as the yield point force applied (newtons) 3 fulcra length (millimeters). Maximum force (newtons) was the load at which the femur broke. Moment of inertia (MOI; millimeters to the fourth power) was calculated as described previously (26) . In addition, 1 femur from each rat was digested in concentrated nitric acid and analyzed for calcium content using inductively coupled plasma optical emission spectrometry (Advanced Laboratories).
Intestinal Calcium transporter expression. Duodenal mucosa were homogenized and lysed using 1.4-mm ceramic spheres and a bench-top homogenizer (lysing matrix D and FastPrep-24; MP Biomedicals), and total RNA was extracted using the RNeasy kit (Qiagen). RNA was subsequently reversed transcribed into cDNA using the High Capacity cDNA Synthesis Kit (Life Technologies). Real-time PCR was performed using TaqMan Fast Advanced Master Mix (Life Technologies), and assays were conducted for the following targets: transient receptor potential cation channel, subfamily V, member 6 (Trpv6; Rn00586673_m1), claudin-2 (Cldn-2; Rn02063575_s1), and b-actin (Rn00667869_m1), which was used as an endogenous control. PCR reactions were conducted using 100 ng of cDNA and the following protocol on an Applied Biosystems StepOnePlus Real-Time PCR System: incubation for 2 min at 50°C, activation for 20 s at 95°C followed by 40 cycles of denaturing for 1 s at 95°C, and annealing/extension for 20 s at 60°C. Expression data are presented as fold change compared with NP-milk-AL using the 2 2DDCt method (27) .
Immunoblotting was performed to quantify protein expression of calcium transporters in the duodenal mucosa. Samples were lysed using radioimmunoprecipitation assay buffer (Millipore) with protease and phosphatase inhibitor tablets (Roche Diagnostics) and homogenized on a bench-top homogenizer (lysing matrix D beads and FastPrep-24; MP Biomedicals). Samples were subsequently centrifuged at 4°C for 5 min at 10,000 3 g, the supernatant was collected, and total protein was quantified using the BCA Assay (Thermo Fisher Scientific). Samples were diluted in LaemmliÕs buffer and boiled at 95°C for 5 min, and 10 mg of total protein was subjected to SDS-PAGE using Criterion TGX precast gels (Bio-Rad Laboratories). Proteins were then transferred to PVDF membranes, blocked in 5% BSA in tris-buffered saline with 0.1% Tween 20 (TBST) for 1 h at room temperature, and incubated with primary antibodies in 5% milk or 5% BSA in TBST overnight at 4°C. The primary antibodies and dilutions were as follows: 1) transient receptor potential cation channel, subfamily V, member 6 (TRPV6), 1:500 (Santa Cruz Biotechnology); 2) Cldn-2, 1:250 (Life Technologies); and 3) b-actin, 1:1000 (Cell Signaling Technology). Membranes were washed with TBST and incubated with anti-rabbit IgG conjugated with horseradish peroxidase, 1:3000 (Cell Signaling Technology) for 1 h at room temperature. Signal intensity was detected using chemiluminescence (SuperSignal, West Pico Kit; Pierce Biotechnology), followed by exposure in a Molecular Imager ChemiDoc XRS (Bio-Rad Laboratories). Band intensity was quantified using Image Lab 4.0 and expressed relative to the NP-milk-AL group.
Statistical analysis. Repeated-measures ANOVA with time as the within-subjects factor (weeks 0, 4, 8, 12, and 16) and food level (F), dietary protein level (L), and S as the between-subjects factors was used to analyze food intake and body weight data. Multivariate ANOVA was used to examine the main effects of the 3 independent factors (F, L, and S) and the interactive effects on measures of bone turnover, BMD, microarchitecture, strength, and duodenal calcium transporters. When a significant interaction was observed, pairwise comparisons were made with BonferroniÕs corrections. Normality was tested using the Kolmogorov-Smirnov test, and non-normally distributed data (P1NP and osteocalcin) were analyzed using Kruskal-Wallis and Mann-Whitney U tests. Data were analyzed using SPSS version 20 (SPSS). Statistical significance was set at P < 0.05. All data are presented as means 6 SEMs; when main or interaction effects were observed, marginal means are reported: F, L, S, F 3 L, F 3 S, L 3 S, or F 3 L 3 S. In the figures, the results in the insets represent marginal means for statistically significant main or interaction effects.
Results
Food intake and body weight. Body weight increased over time, independently of L and S, but was lower for FR compared with AL (454 6 4 vs. 516 6 10 g at 16 wk, respectively, time 3 F, P < 0.001) (Fig. 1) . Food intake was consistent with the study design, because rats that consumed AL diets ate ;25 6 0.7 g/d and rats that consumed FR diets ate 15 g/d. Food intake was similar across varying L and S.
Circulating hormones and markers of bone turnover. Although PTH and serum calcium were not different between the AL and FR groups ( Fig. 2A, B) , FR increased bone turnover as evidenced by the increased bone formation marker P1NP (16.8 6 1.2 vs. 13.4 6 0.8 mg/L, P < 0.05) and resorption marker FIGURE 1 Body weight changes in male rats that consumed differing protein levels and sources during ad libitum or foodrestricted conditions for 16 wk. All values are means 6 SEMs; n = 10 per group. Data were analyzed by ANOVA with BonferroniÕs correction to determine the main effect of food level, dietary protein level, dietary protein source, time, and food level 3 time and protein source 3 time interactions (P , 0.05). *Different from all other weeks within the same food level.
y Different between the ad libitum and restricted groups.
# Different from all other weeks within the same food level except week 0. AL, ad libitum control; FR, 40% food restriction; HP, high protein; NP, normal protein.
Protein intake and bones during food restriction 823 CTX (65.9 6 3.1 vs. 54.2 6 2.8 mg/L, P < 0.01) compared with AL, respectively ( Fig. 2C-E) . FR increased osteocalcin compared with AL conditions, but this difference did not reach statistical significance (41.1 6 2.2 vs. 35.2 6 1.4 ng/L, P = 0.07). Although PTH was lower in rats that consumed HP compared with NP (18.5 6 4.6 vs. 34.2 6 7.1 pmol/L) ( Fig. 2A) , this was not statistically significant (P = 0.06). Serum calcium also did not differ by L (Fig.2B) . However, bone turnover was suppressed in rats consuming HP compared with NP as evidenced by lower osteocalcin (35.5 6 1.9 vs. 40.8 6 1.8 ng/L, P < 0.05) and CTX (55.9 6 3 vs. 64.2 6 3.1 mg/L, P < 0.05) (Fig. 2C-E) . Soy diets resulted in increased serum calcium compared with milk (11.0 6 0.1 vs. 10.5 6 0.1 mg/dL, P < 0.01) and suppressed PTH to a greater extent than milk diets (16.6 6 3.6 vs. 36.1 6 7.5 pmol/L, P < 0.05) (Fig. 2A, B) . Markers of bone turnover were higher in soy compared with milk, because osteocalcin (41.5 6 2.1 vs. 34.8 6 1.6 ng/L, P < 0.01) and CTX (66.7 6 3.3 vs. 53.4 6 2.5 mg/L, P < 0.01) were higher in rats consuming soy compared with milk, respectively, whereas P1NP was not affected by S (Fig. 2C-E) . Circulating IGF-1 was lower during FR compared with AL control (1550 6 36 vs. 1660 6 38 mg/L, P < 0.05) and lower in rats consuming HP compared with NP (1530 6 38 vs. 1690 6 33, P = 0.001) (Fig. 2F) . S also affected circulating IGF-1 amounts because IGF-1 was higher in rats consuming soy compared with milk diets (1750 6 41 vs. 1570 6 58 mg/L, F 3 S, P < 0.05) during AL conditions.
Measures of BMD, microarchitecture, and strength. Although there was no effect of FR on femoral cortical volumetric BMD (vBMD) as assessed by mCT, trabecular vBMD of the FIGURE 2 Circulating bone turnover markers in male rats that consumed differing protein levels and sources during ad libitum or foodrestricted conditions for 16 wk. Parathyroid hormone (A), total calcium (B), osteocalcin (C), procollagen type 1 N-terminal propeptide (D), C-terminal telopeptide (E), and insulin-like growth factor-1 (F). All values are means 6 SEMs; n = 9-10 per group. Data were analyzed by ANOVA with BonferroniÕs correction or Kruskal-Wallis and Mann-Whitney U tests (osteocalcin and procollagen type 1 N-terminal propeptide) to determine the main effect of food level, dietary protein level, dietary protein source, time, and food level 3 time and protein source 3 time interactions (P , 0.05). Inset figures report marginal means when main or interaction effects were observed (P , 0.05). AL, ad libitum control; Ca, calcium; CTX, C-terminal telopeptide; FR, 40% food restriction; HP, high protein; IGF-1, insulin-like growth factor-1; NP, normal protein; OCN, osteocalcin; PTH, parathyroid hormone; P1NP, procollagen type 1 N-terminal propeptide.
distal femur was lower in FR groups compared with AL groups [162 6 12 vs. 190 6 11 mg hydroxypapatite/cm 3 ], although this difference did not reach statistical significance (P = 0.08). Rats consuming restricted diets had reduced femoral trabecular bone volume (BV)/total volume (TV) at the distal femur (18.5 6 0.7 vs. 20.6 6 0.7%, P < 0.05) and reduced cortical area (8.5 6 0.6 vs. 9.3 6 0.7 mm 2 , P < 0.001) and cortical thickness (Ct.Th; 0.76 6 0.06 vs. 0.82 6 0.05 mm, P < 0.001) at the femoral diaphysis compared with AL controls ( Table 2 ). In addition, femoral bone surface (BS)/BV at the femur diaphysis was higher for FR compared with AL (2.63 6 0.02 vs. 2.45 6 0.03 mm 21 , P < 0.001) ( Table 2) . Similarly, femur length (P < 0.01), MOI (P = 0.001), and bending moment (P = 0.01) at the diaphysis were lower in FR rats compared with AL controls (Table 2) . Regardless of S, bone microarchitecture was influenced by L during FR, because femoral BS/BV at the diaphysis was higher (2.69 6 0.05 vs. 2.40 6 0.03 mm 21 , P < 0.001) and Ct.Th was lower (0.73 6 0.01 vs. 0.75 6 0.01 mm, P < 0.001) for the HP-FR groups compared with HP-AL groups (F 3 L, P < 0.05) ( Table 2 ). No such interaction was observed for the NP diets. In contrast to the femur, there were no main or interaction effects of F in the lumbar spine (Supplemental Table 1 ). Similarly, there were no F 3 S interactions on any indicators of bone microarchitecture or strength in the femur.
Although there were no main effects of L on cortical vBMD, trabecular vBMD at the distal femur was higher in rats consuming HP compared with NP (196 6 11 vs. 156 6 12 mg hydroxypapatite/cm 3 , P < 0.05) ( Table 2) . No other main effects of L were observed on any bone variable. S affected both the trabecular and cortical compartments, and several L 3 S interactions were observed. However, the trabecular effects of S differed in the femur compared with the lumbar spine. In the trabecular envelope of the distal femur, milk diets resulted in increased trabecular thickness (0.095 6 0.002 vs. 0.091 6 0.001 mm, P < 0.05) and decreased the structure model index (1.49 6 0.12 vs. 1.67 6 0.10, P < 0.05) compared with soy, and rats consuming the HP-milk diet had the highest trabecular thickness (L 3 S, P < 0.05) ( Table 2 ). In the trabecular envelope of the lumbar spine, vBMD was higher for soy compared with milk (280 6 8 vs. 258 6 7 mg hydroxypapatite/cm 3 , P < 0.05), with the HP-soy group exhibiting the highest vBMD (L 3 S, P < 0.05) (Supplemental Table 1 ). BV/TV for soy (0.30 6 0.01 mm 3 ) was higher (P < 0.05) compared with milk (0.28 6 0.01 mm 3 ) independent of F and L (Supplemental Table 1 ). In addition, rats consuming the HP-soy diet had the highest BV/TV at the spine (L 3 S, P < 0.05) (Supplemental Table 1 ). Consistent with the higher spine BV/TV during HP-soy intake, trabecular number (Tb.N) was higher in the HP-soy groups compared with HP-milk (L 3 S, 3.58 6 0.09 vs. 3.18 6 0.12, P < 0.05) (Supplemental Table 1 ), although there was no effect of S on Tb.N for NP.
In the cortical envelope of the femur diaphysis, soy resulted in higher vBMD (1303 6 10 vs. 1299 6 11 mg hydroxypapatite/ cm 3 , P < 0.05), BV/TV (0.41 6 0.03 vs. 0.40 6 0.03 mm 3 , P < 0.05), and Ct.Th (0.80 6 0.06 vs. 0.78 6 0.06 mm, P < 0.05) and lower BS/BV (2.50 6 0.03 vs. 2.58 6 0.03 mm 21 , P < 0.05) compared with the milk diets (Table 2) . However, bone strength at the femur diaphysis was not affected by S. There were no main or interaction effects of either F or L on bone calcium content as assessed by inductively coupled plasma optical emission spectrometry. However, rats consuming the soy diets had higher bone calcium content compared with those consuming the milk diets (4552 6 42 vs. 4200 6 127 mg calcium/g bone dry weight, P < 0.01).
Intestinal Calcium transporter expression. FR increased Trpv6 mRNA but not protein expression compared with AL conditions (Fig. 3A, B ). An F 3 L interaction was also observed, indicating greater TRPV6 protein expression for HP (1.6 6 0.1-fold) than NP (1.2 6 0.1-fold) during AL conditions (F 3 L interaction, P < 0.05) (Fig. 3B, inset) . HP had an opposite effect on Trpv6 mRNA expression, with lower mRNA levels observed for HP (20.8 6 0.8-fold) compared with NP (2 6 0.7-fold, P < 0.05) (Fig. 3A, inset ). An F 3 S interaction was also observed for TRPV6 protein expression, because soy intake resulted in greater TRPV6 expression (1.6 6 0.1-fold) compared with milk (1.2 6 0.1-fold) during AL conditions (F 3 S interaction, P < 0.05) (Fig. 3B, inset) . Neither mRNA nor protein expression of Cldn-2 were differentially regulated by F, L, or S (Fig. 3C, D) .
Discussion
To our knowledge, this is the first study to evaluate the effects of both L and S on multiple variables of bone health and intestinal calcium transporter expression during AL intake and FR in male rats. The major findings of this study are as follows: 1) FR increased bone turnover and negatively affected bone microarchitecture and strength; 2) HP intake tended to suppress PTH, decreased markers of bone turnover, and increased trabecular vBMD of the distal femur compared with NP intake regardless of F without affecting bone strength at the femur diaphysis; 3) soy further suppressed PTH and increased femoral calcium content and cortical vBMD at the femur diaphysis and improved structure compared with milk but did not alter diaphyseal bone strength; and 4) during AL conditions, both HP and soy diets increased intestinal TRPV6 protein expression.
As hypothesized, a 40% FR resulted in reduced body weight gain, elevated bone turnover, and detrimental effects on bone tissue, including reduced trabecular BV/TV at the distal femur, reduced total area, cortical area, and Ct.Th, and increased BS/ BV in the cortical envelope of the femur diaphysis. As expected from body weight measures, femur length was lower in FR rats, as was MOI and bending moment at the femur diaphysis, indicating reduced bone strength during FR. FR also increased markers of bone turnover measured in this study but had no effect on the amount of circulating PTH. Although trabecular vBMD of the distal femur was lower during FR compared with AL, this did not reach statistical significance (P = 0.08). However, mCT analyses indicated cortical thinning at the femur diaphysis in FR compared with AL conditions. Interestingly, the effects of F were observed at the femur, a weight-bearing bone, but not at the non-weight-bearing lumbar spine, which may have important implications for weight loss regimens combining restriction with exercise.
Consistent with previous reports in humans (28) , HP intake tended to suppress PTH and decrease circulating markers of bone turnover, which is considered beneficial to bone health (23) . An HP diet may suppress circulating PTH as a result of augmented intestinal calcium absorption or through direct effects of circulating aromatic amino acids on the calciumsensing receptor located on the parathyroid cells (29) . Interestingly, although HP intake had a beneficial effect on PTH and bone turnover, HP intake resulted in improved vBMD in the trabecular but not cortical envelope of the distal femur and did not affect strength at the femoral diaphysis. The lack of demonstrated improvements in cortical vBMD may be due to limitations of the rat model because, at 3-7 mo of age, most bone turnover in the rat is attributable to modeling rather than Protein intake and bones during food restriction 825 remodeling, which is the dominant form of bone turnover in adult humans (30) . Thus, L may affect the modeling and remodeling processes differently. The most unexpected finding of the current study was the beneficial effect of a soy-based compared with milk-based diet. Soy isoflavones are unlikely to explain the beneficial effect of a soy-based diet observed in the current study, because the soy protein concentrate used contained very little isoflavone. The soy diet resulted in increased circulating calcium, greater PTH suppression, higher circulating IGF-1 during AL conditions, and improvements in bone microarchitecture and vBMD in both the lumbar spine and the cortical shell at the femur diaphysis and higher bone calcium content of the femur compared with milk. In addition, the HP-soy diet resulted in higher BV/TV and Tb.N at the lumbar spine than HP-milk, whereas there was no effect of S at the NP level. These variables, in particular the increase in femoral cortical and lumbar spine BV/TV, would be expected to increase bone strength, although S and L had no affect on bone strength at the femur diaphysis. The inconsistency in these data may be due to the sensitivity of the 3-point bend test compared with mCT. The improvements in bone variables during soy were likely due, at least in part, to augmented calcium absorption and subsequent PTH suppression. A recent report by Bihuniak et al. (31) suggests that arginine and lysine may be the bioactive amino acids responsible for increasing calcium absorption. Interestingly, the arginine content of the soy diets used in the current study was 55-85% higher than the milk diets (Table 1) , whereas most other amino acids were lower in the soy diets.
In the present study, the beneficial effects of HP and soy intakes on bone turnover and microarchitecture may be partially due to improved intestinal calcium absorption and subsequent PTH suppression. Consistent with this possibility, protein expression of the transcellular calcium transporter TRPV6 increased for HP and soy diets during AL conditions, but no effect of dietary protein on the paracellular calcium channel Cldn-2 was observed. Previous studies indicate that a high (40%) compared with a low (5%) casein diet increases calcium absorption in rats (32) , likely due to augmented transcellular calcium absorption, although no changes in TRPV6 protein level were observed. In the current study, consuming an HP diet for 16 wk increased TRPV6 protein expression. Although this likely has biologic relevance, future work is required to assess the effect of an habitual HP diet on intestinal calcium absorption.
The strengths of this study included the pair-feeding design with careful control of minerals known to affect calcium absorption and bone health. The levels of dietary protein FIGURE 3 mRNA (A, C) and protein (B, D) level expression of calcium channels: TRPV6 and Cldn-2, respectively, isolated from the duodenum of rats that consumed differing protein levels and sources during ad libitum or food-restricted conditions for 16 wk. All values are means 6 SEMs; n = 7-10 per group. Bact was used as loading control, and all data are expressed relative to the NP-Milk-AL group. Data were analyzed by ANOVA with BonferroniÕs correction to determine the main effect of food level, dietary protein level, dietary protein source, time, and food level 3 time and protein source 3 time interactions (P , 0.05). Inset figures report marginal means when main or interaction effects were observed (P , 0.05). AL, ad libitum; Bact, b-actin; Cldn-2, claudin-2; FR, 40% food restriction; HP, high protein; MW, molecular weight; NP, normal protein; TRPV6, transient receptor potential cation channel, subfamily V, member 6.
Protein intake and bones during food restriction 827 provided in all groups were adequate and, therefore, represent a comparison between moderate protein and HP diets rather than protein-deficient and -replete conditions. In addition, the length of the feeding trial was sufficient to detect effects of both L and S on bone outcomes rather than proxy measures. One limitation of this study was that the FR did not induce weight loss, but it did limit growth. Additionally, calcium restriction accompanied the ER, which may have modulated the impact of L on bone health during restriction (10) . In addition, we used a male rat model, and thus findings may or may not extend to females. Our intent was to develop a model for mechanistic exploration to further expand on our previous work in a population that is reflective of the U.S. military populations (17) (18) (19) (20) . Previous work in female rats suggests that ER has negative effects on bone (33) , whereas the effects of ER on bone in male rats are not as consistent (34, 35) . However, limited data in humans suggest that the effects of dietary protein on bone during weight loss do not differ between young men and women (11) , although females may be at greater risk of ER as evidenced by the prevalence of the female athlete triad (36) . Finally, although L and S affected bone microarchitecture, no effects on bone strength were detected. Direct strength measures were limited to the femoral diaphysis, which is a cortical site. However, all the observed effects of L were in the trabecular envelope, and thus, the possibility that HP intake improved bone strength at the distal femur or spine cannot be excluded. Regardless, in the present study, important effects of L on PTH, circulating markers of bone turnover, trabecular vBMD, and intestinal calcium transporter expression were observed.
In conclusion, FR increased bone turnover and negatively affected bone microarchitecture and strength in male rats. HP diets tended to suppress PTH, decreased bone turnover, and increased trabecular vBMD of the distal femur compared with NP diets but did not affect bone strength at the diaphysis. S differentially affected bone turnover and quality. Milk suppressed bone turnover compared with soy, whereas soy suppressed PTH and improved some measures of bone microarchitecture and cortical vBMD of the distal femur and trabecular BMD of the lumbar spine and increased bone calcium content compared with milk. During AL conditions, both HP and soy intakes increased protein expression of duodenal TRPV6, suggesting that improved calcium absorption may be 1 mechanism by which HP and soy improve bone health.
